Pacific Shuanglin Bio-pharmacy Co., LTD (SHE: 000403)
China flag China · Delayed Price · Currency is CNY
22.90
-0.69 (-2.93%)
Oct 11, 2024, 3:04 PM CST

Pacific Shuanglin Bio-pharmacy Co., LTD Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Oct '24 Dec '23 Jan '23 Jan '22 Jan '21 Jan '20 2019 - 2015
Market Capitalization
16,74219,95716,66920,54018,7138,804
Upgrade
Market Cap Growth
33.28%19.73%-18.85%9.77%112.54%28.28%
Upgrade
Enterprise Value
15,56318,99015,72519,92818,9278,826
Upgrade
Last Close Price
22.9027.0422.4927.6337.4617.71
Upgrade
PE Ratio
21.0032.2528.0149.9798.7653.99
Upgrade
PS Ratio
6.078.576.9310.4217.829.62
Upgrade
PB Ratio
2.202.692.433.2519.3510.98
Upgrade
P/FCF Ratio
58.6066.14114.50250.30120.9958.80
Upgrade
P/OCF Ratio
30.6729.3931.8050.3296.0446.13
Upgrade
EV/Sales Ratio
5.658.156.5410.1118.039.64
Upgrade
EV/EBITDA Ratio
15.7624.7322.3237.0469.0937.21
Upgrade
EV/EBIT Ratio
18.3029.9726.7946.3283.5346.24
Upgrade
EV/FCF Ratio
54.4762.93108.02242.85122.3858.95
Upgrade
Debt / Equity Ratio
0.070.070.050.020.390.14
Upgrade
Debt / EBITDA Ratio
0.540.640.520.261.390.46
Upgrade
Debt / FCF Ratio
1.861.642.561.722.460.73
Upgrade
Asset Turnover
0.330.280.320.450.710.71
Upgrade
Inventory Turnover
1.311.471.691.801.271.10
Upgrade
Quick Ratio
2.452.702.462.670.650.84
Upgrade
Current Ratio
3.723.723.183.841.351.77
Upgrade
Return on Equity (ROE)
10.94%8.56%8.91%10.73%20.66%22.18%
Upgrade
Return on Assets (ROA)
6.28%4.77%4.87%6.13%9.60%9.21%
Upgrade
Return on Capital (ROIC)
6.84%5.23%5.35%6.88%12.54%13.93%
Upgrade
Earnings Yield
4.76%3.07%3.52%1.90%0.99%1.82%
Upgrade
FCF Yield
1.71%1.51%0.87%0.40%0.83%1.70%
Upgrade
Dividend Yield
0.85%0.74%0.36%0.20%-0.38%
Upgrade
Payout Ratio
27.11%10.91%8.46%3.08%96.17%90.13%
Upgrade
Buyback Yield / Dilution
0.15%0.12%-3.37%-44.24%-0.23%0.00%
Upgrade
Total Shareholder Return
1.00%0.86%-3.01%-44.03%-0.23%0.38%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.